These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

915 related items for PubMed ID: 21412368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Damron KS, McManus CD, Brandon DE.
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [Abstract] [Full Text] [Related]

  • 3. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR, Tracy DH, Vallejo R, Wargo BW, American Society of Interventional Pain Physicians.
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [Abstract] [Full Text] [Related]

  • 4. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L, Malla Y, Wargo BW, Fellows B.
    Pain Physician; 2011 Jul; 14(2):175-87. PubMed ID: 21412372
    [Abstract] [Full Text] [Related]

  • 5. The role of urine drug testing for patients on opioid therapy.
    Pergolizzi J, Pappagallo M, Stauffer J, Gharibo C, Fortner N, De Jesus MN, Brennan MJ, Richmond C, Hussey D, Integrated Drug Compliance Study Group (IDCSG).
    Pain Pract; 2010 Jul; 10(6):497-507. PubMed ID: 20412503
    [Abstract] [Full Text] [Related]

  • 6. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
    McCarberg BH.
    Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
    [Abstract] [Full Text] [Related]

  • 7. Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility.
    Manchikanti L, Atluri S, Trescot AM, Giordano J.
    Pain Physician; 2008 Mar; 11(2 Suppl):S155-80. PubMed ID: 18443638
    [Abstract] [Full Text] [Related]

  • 8. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A, Patton C, Diskina D, Cheatle M.
    Pain Physician; 2011 Mar; 14(4):383-9. PubMed ID: 21785482
    [Abstract] [Full Text] [Related]

  • 9. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N, Manchikanti L, Smith HS.
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [Abstract] [Full Text] [Related]

  • 10. Urine drug testing: current recommendations and best practices.
    Owen GT, Burton AW, Schade CM, Passik S.
    Pain Physician; 2012 Jul; 15(3 Suppl):ES119-33. PubMed ID: 22786451
    [Abstract] [Full Text] [Related]

  • 11. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH.
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [Abstract] [Full Text] [Related]

  • 12. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
    Chakravarthy K, Goel A, Jeha GM, Kaye AD, Christo PJ.
    Curr Pain Headache Rep; 2021 Feb 17; 25(2):12. PubMed ID: 33598816
    [Abstract] [Full Text] [Related]

  • 13. Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion.
    McCarberg BH.
    Postgrad Med; 2011 Mar 17; 123(2):119-30. PubMed ID: 21474900
    [Abstract] [Full Text] [Related]

  • 14. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.
    Ives TJ, Chelminski PR, Hammett-Stabler CA, Malone RM, Perhac JS, Potisek NM, Shilliday BB, DeWalt DA, Pignone MP.
    BMC Health Serv Res; 2006 Apr 04; 6():46. PubMed ID: 16595013
    [Abstract] [Full Text] [Related]

  • 15. Breakthrough pain in chronic non-cancer pain: fact, fiction, or abuse.
    Manchikanti L, Singh V, Caraway DL, Benyamin RM.
    Pain Physician; 2011 Apr 04; 14(2):E103-17. PubMed ID: 21412376
    [Abstract] [Full Text] [Related]

  • 16. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L, Kaye AM, Knezevic NN, McAnally H, Slavin K, Trescot AM, Blank S, Pampati V, Abdi S, Grider JS, Kaye AD, Manchikanti KN, Cordner H, Gharibo CG, Harned ME, Albers SL, Atluri S, Aydin SM, Bakshi S, Barkin RL, Benyamin RM, Boswell MV, Buenaventura RM, Calodney AK, Cedeno DL, Datta S, Deer TR, Fellows B, Galan V, Grami V, Hansen H, Helm Ii S, Justiz R, Koyyalagunta D, Malla Y, Navani A, Nouri KH, Pasupuleti R, Sehgal N, Silverman SM, Simopoulos TT, Singh V, Solanki DR, Staats PS, Vallejo R, Wargo BW, Watanabe A, Hirsch JA.
    Pain Physician; 2017 Feb 04; 20(2S):S3-S92. PubMed ID: 28226332
    [Abstract] [Full Text] [Related]

  • 17. Urine toxicology testing in chronic pain management.
    Cone EJ, Caplan YH.
    Postgrad Med; 2009 Jul 04; 121(4):91-102. PubMed ID: 19641275
    [Abstract] [Full Text] [Related]

  • 18. Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse.
    Solanki DR, Koyyalagunta D, Shah RV, Silverman SM, Manchikanti L.
    Pain Physician; 2011 Jul 04; 14(2):E119-31. PubMed ID: 21412377
    [Abstract] [Full Text] [Related]

  • 19. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR, Tracy DH, Vallejo R, Wargo BW, American Society of Interventional Pain Physicians.
    Pain Physician; 2012 Jul 04; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [Abstract] [Full Text] [Related]

  • 20. The role of urine toxicology in chronic opioid analgesic therapy.
    Compton P.
    Pain Manag Nurs; 2007 Dec 04; 8(4):166-72. PubMed ID: 18036504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.